Halozyme Therapeutics HALO
NASDAQ HALO
$109.86 +2.92 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Profit After Tax (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) posted Profit After Tax of $229.9 million for Q2 2026, up 39.2% from $165.16 million a year earlier and up 53.2% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Profit After Tax (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Profit After Tax at Halozyme Therapeutics was $413.56 million, down 25.8% year-over-year; for FY2025, it was $316.89 million, down 28.6% from FY2024.

  • Annual Profit After Tax shows a five-year compound annual growth rate of 19.7% (FY2020 to FY2025).
  • In prior years, Halozyme Therapeutics' Profit After Tax was $444.09 million in FY2024 (+57.7%), $281.59 million in FY2023 (+39.3%), $202.13 million in FY2022 (-49.8%) and $402.71 million in FY2021 (+212.0%).
  • The Q2 2026 figure stands as the highest quarterly Profit After Tax in data going back to Q2 2010.
  • The strongest year-over-year quarter for Profit After Tax in the past five years was Q3 2021, with growth of 498.2%; the weakest was Q2 2022, with a decline of 75.2%.
  • According to Business Quant data, Profit After Tax for the three prior quarters was $150.03 million (Q1 2026), -$141.59 million (Q4 2025) and $175.23 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 5.28 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 3.09 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -246.00 Mn
10 Halozyme Therapeutics 12.53 Bn 11.13 Bn 401.83 Mn 229.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 229.90 Mn
Mar 31, 2026 150.03 Mn
Dec 31, 2025 -141.59 Mn
Sep 30, 2025 175.23 Mn
Jun 30, 2025 165.16 Mn
Mar 31, 2025 118.10 Mn
Dec 31, 2024 137.01 Mn
Sep 30, 2024 137.01 Mn
Jun 30, 2024 93.25 Mn
Mar 31, 2024 76.82 Mn
Dec 31, 2023 85.39 Mn
Sep 30, 2023 81.84 Mn
Jun 30, 2023 74.75 Mn
Mar 31, 2023 39.62 Mn
Dec 31, 2022 57.70 Mn
Sep 30, 2022 61.63 Mn
Jun 30, 2022 22.69 Mn
Mar 31, 2022 60.11 Mn
Dec 31, 2021 66.77 Mn
Sep 30, 2021 216.59 Mn
API Access

Halozyme Therapeutics Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=HALO&period=max&api_key=YOUR_API_KEY